Ask Our Doctors and Nurses!

ETOPOSIDE Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

ETOPOSIDE Safety Reports

Total ETOPOSIDE reports: 202.
ETOPOSIDE FDA safety alerts: No.
Reported deaths: 46    Reported hospitalizations: 76.
Take ETOPOSIDE Side Effects Survey or Share Your ETOPOSIDE Story. Read More Here.

Showing 1-75 of 202 Next >

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: paraesthesia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pneumonia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pneumonia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pneumonia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Physician from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Physician from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pneumonia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pneumonia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pneumonia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pneumonia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died.

Physician from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Physician from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Physician from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Physician from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Physician from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pneumonia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 12, 2006. Female patient was diagnosed with small cell lung cancer limited stage and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiovascular disorder. ETOPOSIDE dosage: 80 MG/M2, DAY 1, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, DEXAMETHASONE. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 12, 2006. Female patient was diagnosed with small cell lung cancer limited stage and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiotoxicity. ETOPOSIDE dosage: 80 MG/M2, DAY 1, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, DEXAMETHASONE. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 12, 2006. Female patient was diagnosed with small cell lung cancer limited stage and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: neutropenic sepsis. ETOPOSIDE dosage: 80 MG/M2, DAY 1, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, DEXAMETHASONE, GRANULOCYTE COLONY STIMULATING FACTOR. Patient died.

ETOPOSIDE problem was reported by a Pharmacist from UNITED STATES on Jan 12, 2006. Female patient, child 2 years of age, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, bronchospasm, cough, respiratory distress. ETOPOSIDE dosage: 106 MG/IV/ X1. Patient recovered.

Pharmacist from UNITED STATES reported ETOPOSIDE problem on June 09, 2006. Male patient, 74 years of age, weighting 121.3 lb, was diagnosed with gastric cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: extravasation. ETOPOSIDE dosage: 120 MG/IV/ DAILY FOR 3 DAYS. Patient recovered.

ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 26, 2006. Male patient, 25 years of age, was diagnosed with testis cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: arthralgia, groin pain, osteonecrosis. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, BLEOMYCIN SULPHATE, DEXAMETHASONE. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on June 29, 2006. Female patient, 48 years of age, was diagnosed with metastatic neoplasm and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. ETOPOSIDE dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient died on 05/31/2006.

ETOPOSIDE problem was reported by a Consumer or non-health professional from FRANCE on July 19, 2006. Male patient was diagnosed with metastatic neoplasm, neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, renal failure acute, renal tubular necrosis, transaminases increased. ETOPOSIDE dosage: 130 MILLIGRAM INTRAVENOUS (NOS). During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, VINCRISTINE SULPHATE, METOPIMAZINE, LENOGRASTIM. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on July 12, 2006. Female patient, 71 years of age, was diagnosed with ovarian cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. ETOPOSIDE dosage: unknown. Patient died.

ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 16, 2006. Male patient, 75 years of age, weighting 251.3 lb, was diagnosed with neuroendocrine carcinoma of the skin and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pulmonary alveolar haemorrhage. ETOPOSIDE dosage: unknown. During the same period patient was treated with DECADRON, ZOFRAN, CISPLATIN, SIMVASTATIN, METOPROLOL, VALSARTAN, PROCHLORPERAZINE. Patient was hospitalized and became disabled. Patient recovered.

Physician from JAPAN reported ETOPOSIDE problem on Aug 03, 2006. Male patient, 33 years of age, was diagnosed with testis cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute febrile neutrophilic dermatosis, body temperature increased, chest pain, dysponesis, injection site phlebitis, septic embolus, staphylococcal sepsis, white blood cell count abnormal. ETOPOSIDE dosage: 1500 MG/M2. During the same period patient was treated with CARBOPLATIN, TAXOL, IFOSFAMIDE. Patient recovered.

ETOPOSIDE problem was reported by a Physician from GERMANY on Aug 02, 2006. Male patient, child 10 years of age, was diagnosed with primitive neuroectodermal tumour and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: aspergillosis, gastrointestinal fungal infection. ETOPOSIDE dosage: 250 MG/M2, DAILY X 4 DAYS, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, THIOTEPA. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ETOPOSIDE problem on Aug 04, 2006. Male patient, 74 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, pneumonia, productive cough, respiratory failure, respiratory tract infection. ETOPOSIDE dosage: 50MG/M2/IV. Patient was hospitalized. Patient died on 06/28/2006.

ETOPOSIDE problem was reported by a Health Professional from JAPAN on Aug 21, 2006. Female patient, 45 years of age, was diagnosed with gestational trophoblastic tumour and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pancytopenia, sepsis. ETOPOSIDE dosage: unknown. During the same period patient was treated with BLEOMYCIN SULPHATE, METHOTREXATE, FOLIC ACID, FOLIC ACID. Patient died.

Health Professional from UNITED STATES reported ETOPOSIDE problem on Aug 08, 2005. Female patient, 30 years of age, was diagnosed with ovarian cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, petechiae. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, BLEOMYCIN, BIRTH CONTROL. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from DENMARK on Sept 11, 2006. Female patient, 55 years of age, was diagnosed with lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: thrombophlebitis. ETOPOSIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOSPORINE, PREDNISOLONE. Patient recovered.

Health Professional from JAPAN reported ETOPOSIDE problem on Aug 21, 2006. Female patient, 45 years of age, was diagnosed with gestational trophoblastic tumour and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pancytopenia, sepsis. ETOPOSIDE dosage: unknown. During the same period patient was treated with BLEOMYCIN SULPHATE, METHOTREXATE, FOLIC ACID, FOLIC ACID. Patient died.

ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Female patient, weighting 155.2 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: diarrhoea. ETOPOSIDE dosage: 154 MG. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Sept 21, 2006. Male patient, 73 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: respiratory failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, DELIX, VIANI, METOCLOPRAMIDE, TAVOR, ZOFRAN, ZOPICLONE. Patient was hospitalized. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on May 23, 2006. Female patient, 53 years of age, weighting 185.2 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cardiomegaly, ejection fraction decreased. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, MITOXANTRONE, ZOFRAN, SINGULAIR, ATROVENT, WELLBUTRIN, LEXAPRO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Sept 21, 2006. Male patient, 73 years of age, weighting 1340 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: respiratory failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, DELIX, VIANI, METOCLOPRAMIDE, TAVOR, ZOFRAN, ZOPICLONE. Patient was hospitalized. Patient recovered.

ETOPOSIDE problem was reported by a Physician from UNITED STATES on Sept 22, 2006. Male patient, child 5 years of age, was diagnosed with primitive neuroectodermal tumour and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myelitis transverse, paraplegia. ETOPOSIDE dosage: 250 MG/M**2, DAYS 5, 4 + 3. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, CARBOPLATIN, THIOTEPA, HEMATOPOETIC PROGENITOR CELLS, GRANULOCYTE COLONY STIMULATING FACTOR. Patient recovered.

Physician from UNITED STATES reported ETOPOSIDE problem on Sept 22, 2006. Female patient, 18 years of age, was diagnosed with primitive neuroectodermal tumour and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myelitis transverse, walking aid user. ETOPOSIDE dosage: 250 MG/M**2, DAYS 5, 4 + 3. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, CARBOPLATIN, THIOTEPA, HEMATOPOETIC PROGENITOR CELLS, GRANULOCYTE COLONY STIMULATING FACTOR, ACYCLOVIR. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on Aug 08, 2005. Female patient, 30 years of age, was diagnosed with ovarian cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, petechiae. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, BLEOMYCIN, BIRTH CONTROL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Oct 11, 2006. Female patient, 37 years of age, was diagnosed with choriocarcinoma, metastases to lung and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: arthralgia, bone marrow failure, dyspnoea, nephropathy toxic, stomatitis. ETOPOSIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, COSMEGEN, VINCRISTINE. Patient recovered.

ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Male patient, 40 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, chronic myeloid leukaemia, monocytosis, splenomegaly, thrombocytopenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, DAUNORUBICIN, METHOTREXATE, CYTARABINE. Patient recovered.

Physician from UNITED STATES reported ETOPOSIDE problem on Oct 03, 2006. Male patient, 71 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: immunosuppression, tuberculosis. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from AUSTRALIA on Oct 17, 2006. Female patient, 50 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, culture urine positive, escherichia infection, febrile neutropenia, lung consolidation, neutrophil count decreased, pain, perianal abscess, pyrexia. ETOPOSIDE dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRALIA reported ETOPOSIDE problem on Oct 23, 2006. Female patient, 58 years of age, was diagnosed with malignant lymphoid neoplasm, prophylaxis and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, pollakiuria. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, IFOSFAMIDE, MESNA, RITUXIMAB. Patient was hospitalized. Patient recovered.

ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 11, 2006. Male patient, 22 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: mucoepidermoid carcinoma, salivary gland cancer. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ETOPOSIDE problem on Oct 26, 2006. Male patient, 65 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pericarditis. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, TREOSULFAN. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on Nov 06, 2006. Male patient, 22 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: salivary gland cancer. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, HEMATOPOETIC PROGENITOR CELLS. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported ETOPOSIDE problem on Nov 08, 2006. Female patient, 14 years of age, was diagnosed with ovarian cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: deafness neurosensory, malignant neoplasm progression, nephropathy toxic, neurotoxicity, ototoxicity, peripheral sensory neuropathy, renal failure, renal tubular necrosis. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, ETHYOL. Patient died.

ETOPOSIDE problem was reported by a Health Professional from BELGIUM on June 06, 2006. Male patient, 40 years of age, was diagnosed with germ cell cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOL, BLEOMYCIN SULPHATE, MAGNESIUM OXIDE, METOCLOPRAMIDE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Health Professional from BELGIUM reported ETOPOSIDE problem on Nov 13, 2006. Male patient, 34 years of age, weighting 55.12 lb, was diagnosed with germ cell cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOL, BLEOMYCIN SULPHATE. Patient was hospitalized. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from FRANCE on Oct 26, 2006. Male patient, 32 years of age, was diagnosed with testis cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anxiety, bradycardia, brain herniation, cerebral ischaemia, chills, dyspnoea, enterococcal infection, escherichia infection. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, LENOGRASTIM. Patient died.

Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Nov 14, 2006. Female patient, child 3 years of age, weighting 28.66 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cystitis haemorrhagic, haematuria, hypertension, proteinuria, pulmonary oedema, renal failure acute. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, CARBOPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.

ETOPOSIDE problem was reported by a Health Professional from NORWAY on Oct 30, 2006. Male patient, 29 years of age, was diagnosed with testicular cancer metastatic and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cardiac arrest, dehydration, dialysis, gastritis, metastases to lung, pericarditis, peritoneal disorder, procedural complication. ETOPOSIDE dosage: 950 MG DAILY. During the same period patient was treated with CARBOPLATIN, ZOFRAN, DUSSELDORF BLANDING, CYCLOPHOSPHAMIDE, MESNA, FORTUM, MYCOSTATIN, PARACET. Patient died on 10/01/2006.

Health Professional from UNITED STATES reported ETOPOSIDE problem on Dec 06, 2005. Female patient, 53 years of age, weighting 152.1 lb, was diagnosed with ovarian cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: flushing, restlessness, tremor. ETOPOSIDE dosage: unknown. Patient recovered.

Showing 1-75 of 202 Next >